Literature DB >> 8479524

Solution structure of the POU-specific DNA-binding domain of Oct-1.

N Dekker1, M Cox, R Boelens, C P Verrijzer, P C van der Vliet, R Kaptein.   

Abstract

The transcription factor Oct-1 belongs to a family containing a POU DNA-binding domain. This bipartite domain is composed of a POU-specific domain (POUs) and a POU-homeodomain (POUhd) connected by a flexible linker. The left half of the optimal POU binding site, the octamer ATGCAAAT, is recognized by POUs and the right half by POUhd. We have determined the solution structure of POUs by nuclear magnetic resonance. It consists of four alpha-helices connected by short loops. Helices I and IV are in a parallel coiled-coil arrangement. The folding topology appears to be similar to that of the bacteriophage lambda-repressor and 434 repressor. For the well defined parts of the protein (residues 1-71), the average root-mean square deviation for the backbone atoms is 0.9 A. Based on the observed selective exchange broadening in the (15N,1H)-HMQC (heteronuclear multiple quantum coherence) spectrum of the POUs-DNA complex we conclude that DNA-binding is mediated by helix III. We propose a model for the POU-DNA complex in which both recognition helices from the two subdomains have adjacent positions in the major groove.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479524     DOI: 10.1038/362852a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

1.  The homeodomain resource: a prototype database for a large protein family.

Authors:  S Banerjee-Basu; J F Ryan; A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The Homeodomain Resource: sequences, structures, DNA binding sites and genomic information.

Authors:  S Banerjee-Basu; D W Sink; A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface.

Authors:  D Chasman; K Cepek; P A Sharp; C O Pabo
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

4.  Molecular evolution of the homeodomain family of transcription factors.

Authors:  S Banerjee-Basu; A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

5.  Solution structure and DNA-binding properties of the C-terminal domain of UvrC from E.coli.

Authors:  S Singh; G E Folkers; A M J J Bonvin; R Boelens; R Wechselberger; A Niztayev; R Kaptein
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

6.  The Homeodomain Resource: 2003 update.

Authors:  Sharmila Banerjee-Basu; Travis Moreland; Benjamin J Hsu; Kenneth L Trout; Andreas D Baxevanis
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

7.  Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.

Authors:  Xue-feng Fang; Wei-yi Zhang; Na Zhao; Wei Yu; Dong Ding; Xu Hong; Li-sha Li; Hua-rong Zhang; Shu Zheng; Biao-yang Lin
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

8.  Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1.

Authors:  Bor-Ruei Lin; Ven Natarajan
Journal:  Gene       Date:  2012-01-28       Impact factor: 3.688

9.  Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.

Authors:  G Elif Karagöz; Afonso M S Duarte; Elias Akoury; Hans Ippel; Jacek Biernat; Tania Morán Luengo; Martina Radli; Tatiana Didenko; Bryce A Nordhues; Dmitry B Veprintsev; Chad A Dickey; Eckhard Mandelkow; Markus Zweckstetter; Rolf Boelens; Tobias Madl; Stefan G D Rüdiger
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

10.  NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication.

Authors:  Monika E Mysiak; Claire Wyman; P Elly Holthuizen; Peter C van der Vliet
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.